AMGN vs EVR · P/E 24, rev $10.05B vs P/E 21, rev $998.5M
Amgen Inc (AMGN) versus Evercore Partners Inc (EVR) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Evercore Partners Inc (EVR) is a capital markets company listed on NYSE.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported EVR revenue for 2026-06-30 was $998.5M. Net income was $95.3M. Revenue was down 28.7% from 2026-03-31 to 2026-06-30. EVR currently screens at market cap $14.20B and trailing P/E 20.7.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. EVR currently screens at market cap $14.20B and trailing P/E 20.7.
Not investment advice. Open the AMGN and EVR stock pages for the full models.
Not investment advice.